ADORA2A rs1801175: Understanding Caffeine Sensitivity and Sleep
The rs1801175 variant is a genetic change located within the ADORA2A gene, which encodes the adenosine A2A receptor. This receptor is involved in regulating sleep, arousal, and the physiological response to caffeine.
What each genotype means
Lower caffeine-induced anxiety
This genotype is associated with a reduced susceptibility to caffeine-induced anxiety compared to those carrying the T allele. Research suggests that individuals with this profile may experience fewer jittery or anxious symptoms after moderate caffeine intake. Please discuss any concerns regarding caffeine sensitivity or sleep quality with your healthcare provider.
This genotype is common, appearing in a significant portion of the population alongside the CT genotype.
Intermediate caffeine sensitivity
This genotype represents a heterozygous state that may result in an intermediate response to caffeine-induced anxiety and sleep disruption. Because individual responses to caffeine are complex and influenced by many factors, this profile does not guarantee a specific reaction. If you notice that caffeine affects your sleep or anxiety levels, consider discussing your intake habits with a clinician or pharmacist.
This is a very common genotype found across diverse global populations.
Higher caffeine-induced anxiety
Research indicates that individuals with this genotype may be more susceptible to caffeine-induced anxiety and potential sleep architecture disruption. This variant, sometimes referred to in older literature as 1083T>C, is linked to how the adenosine A2A receptor mediates the effects of caffeine in the brain. If you find that caffeine consumption negatively impacts your anxiety or sleep, you may wish to discuss your caffeine intake with a healthcare professional.
This genotype is observed frequently, with the minor allele frequency for this variant estimated at approximately 0.40-0.45 across many global populations.
What is the rs1801175 Variant?
The rs1801175 variant is a single-nucleotide polymorphism (SNP) found within the ADORA2A gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is located in a gene responsible for producing the adenosine A2A receptor, a protein that plays a critical role in the central nervous system. By interacting with adenosine, a chemical that builds up in the brain throughout the day to promote sleepiness, this receptor helps modulate wakefulness and arousal. Because caffeine functions by blocking adenosine receptors, variations in the gene that codes for these receptors may theoretically influence how an individual perceives the stimulating effects of caffeine, such as increased alertness or, conversely, feelings of jitteriness and sleep disruption.
The Role of the ADORA2A Gene
The ADORA2A gene provides instructions for making the adenosine A2A receptor. This receptor is widely expressed in the brain, particularly in areas involved in motor control, mood regulation, and the sleep-wake cycle. Adenosine acts as a neuromodulator, and when it binds to the A2A receptor, it typically promotes sleep and suppresses arousal. Caffeine is a well-known adenosine receptor antagonist, meaning it binds to these receptors without activating them, effectively blocking the natural sleep-promoting signal of adenosine. Because of this mechanism, researchers have long investigated whether genetic differences in the ADORA2A gene might explain why some people feel highly sensitive to caffeine—experiencing anxiety or insomnia after a single cup—while others can consume large amounts with little to no effect on their sleep quality or mood.
Research and Evidence Strength
Research into ADORA2A variants, including rs1801175, has primarily focused on their potential to influence caffeine-induced anxiety and sleep architecture. While some studies have suggested that certain genotypes may correlate with increased sensitivity to caffeine's effects on sleep or panic symptoms, the evidence remains limited and sometimes inconsistent. For instance, while specific variants in the ADORA2A region have been linked to subjective reports of caffeine-induced anxiety in some adult populations, other large-scale studies have failed to replicate these findings, particularly in different age groups or across diverse ancestries. It is important to note that complex traits like sleep quality and anxiety are influenced by a vast array of genetic, environmental, and lifestyle factors. Consequently, a single SNP like rs1801175 is unlikely to be the sole determinant of how an individual responds to caffeine.
Population Frequency
The minor allele frequency for this variant is generally reported to be between 0.40 and 0.45 across various global populations. This indicates that the variant is relatively common, and individuals carrying different combinations of the alleles are found frequently in the general population.
Interpreting Your Genetic Information
If you have access to your genetic data regarding the rs1801175 variant, it is essential to view this information as only one small piece of a much larger biological puzzle. Genetic associations with caffeine sensitivity are not diagnostic; they do not predict with certainty how you will react to a specific dose of caffeine. Many factors, including your overall health, daily caffeine intake habits, stress levels, and other genetic variants, contribute to your individual experience. You should never use this information to make medical decisions or to self-diagnose conditions like anxiety or sleep disorders. If you have concerns about your sleep quality, persistent anxiety, or how caffeine affects your daily life, the most appropriate course of action is to consult with a qualified healthcare professional or a registered dietitian who can provide personalized guidance based on your clinical history.
How common is this variant?
The minor allele frequency for rs1801175 is approximately 0.40-0.45 across global populations, making the various genotypes relatively common.
Frequently asked questions
Does my ADORA2A genotype mean I should stop drinking coffee?
No. Genetic variants like rs1801175 are associated with statistical trends in populations and do not dictate your personal response to caffeine. If you are concerned about how caffeine affects your sleep or anxiety, discuss your habits with a healthcare provider.
Can this test diagnose an anxiety disorder?
No. Genetic testing for this variant is not a diagnostic tool for anxiety or any other medical condition. Anxiety is a complex condition influenced by many genetic and environmental factors.
Is this variant the same as the one often cited in caffeine studies?
Research often focuses on several variants within the ADORA2A gene, such as rs5751876. While they are in the same gene, they are distinct markers, and findings for one cannot be automatically applied to another.
Where can I learn more about my specific genetic results?
You should consult with a genetic counselor or your primary care physician. They can help you interpret your results in the context of your overall health and family history.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801175?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADORA2A
The T allele of this variant is associated with increased caffeine-induced anxiety and sleep disturbances.
This variant is associated with individual differences in caffeine sensitivity and sleep patterns.
Functional regulatory variant modulating adenosine A2A receptor transcription, sleep EEG slow-wave power, and caffeine-induced sleep disruption.
A synonymous polymorphism tightly linked to rs1801175 in ADORA2A that modulates caffeine-provoked panic disorder susceptibility and electroencephalographic arousal.
Key adenosine A2A receptor regulatory variant influencing caffeine-induced sleep disturbance, slow-wave sleep reduction, and anxiety-related insomnia.